Scalp And Hair Conditions Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Dandruff is considered to be a mild form of _______________

A

seborrhoeic dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Shampoos containing _____________ agents such as pyrithione zinc (which are widely available) and selenium may have beneficial effects in the treatment of dandruff

A

antimicrobial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Shampoos containing antimicrobial agents such as ______________ (which are widely available) and ______________ may have beneficial effects

A

pyrithione zinc

selenium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Shampoos containing _____________ extracts may be useful and they are also used in psoriasis

A

tar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

_____________ shampoo should be considered for more persistent or severe dandruff or for seborrhoeic dermatitis of the scalp

A

Ketoconazole

*Corticosteroid gels and lotions can also be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cradle cap in infants may be treated with _____________ or _____________ applications followed by shampooing

A

coconut oil

olive oil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is cradle cap?

A

Seborrheic dermatitis; crusty or oily scaly patches on a baby’s sclap; probably caused by maternal hormones that cause oil glands on the skin to become overactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which drugs may cause hirsutism? (6)

A
  1. Minoxidil (used to promote hair growth)
  2. Corticosteroids
  3. Anabolic steroids
  4. Androgens
  5. Danazol
  6. Progestogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of minoxidil?

A

Shortens the telogen (resting) phase of the hair growth cycle, moving hair into the anagen (active growth) phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the phases of the hair growth cycle? (3)

A
  1. Anagen phase: hair grows to its full length; 85-90% of hairs are in this phase at any one time; lasts 2-6 years, during which time the hair grows continuously
  2. Catagen phase: transitional stage; lasts about 2-3 weeks; growth stops and outer root sheath shrinks and attaches to the root of the hair
  3. Telogen phase: entire hair structure rests for several months; phase lasts for ~100 days; about 25-100 telogen hairs are shed normally each day
    (Then re-enters anagen phases)

*minoxidil improves blood flow to scalp, shortening telogen phase to promote hair growth and improve thickness, density, and overall health of hair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

_________________ can reduce hirsutism in obese women

A

Weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Women should be advised about local methods of ______________, and in the mildest cases of hirsutism this may be all that is required.

A

hair removal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Eflornithine a(n) ______________ drug, inhibits the enzyme ornithine decarboxylase in hair follicles. Topical eflornithine can be used as an adjunct to laser therapy for facial hirsutism in women.

A

antiprotozoal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Topical ______________, an antiprotazoal drug, can be used as an adjunct to laser therapy for facial hirsutism in women.

A

eflornithine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

_______________ (cyproterone acetate with ethinylestradiol) may be effective for moderately severe hirsutism

A

Co-cyprindiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Co-cyprindiol (_____________ with ______________) may be effective for moderately severe hirsutism

A

cyproterone acetate (an anti-androgen)

ethinylestradiol

17
Q

______________ is an alternative to co-cyprindiol in women with hirsutism secondary to polycystic ovary syndrome [unlicensed indication]

A

Metformin hydrochloride

  • Systemic treatment is required for 6–12 months before benefit is seen
18
Q

The MHRA/CHM have released important safety information regarding the use of cyproterone acetate and the risk of _______________.

A

meningioma

Cyproterone acetate is a component of co-cyprindiol

19
Q

______________ is licensed for the treatment of androgenetic alopecia in men

A

Finasteride

  • Continuous use for 3–6 months is required before benefit is seen, and effects are reversed 6–12 months after treatment is discontinued
20
Q

Finasteride is licensed for the treatment of _____________ alopecia in men

A

androgenetic

  • Continuous use for 3–6 months is required before benefit is seen, and effects are reversed 6–12 months after treatment is discontinued
21
Q

Topical application of minoxidil may stimulate limited hair growth in a small proportion of adults but only for as long as ______________

A

it is used

22
Q

What are the common side effects of eflornithine? (4)

A
  1. Alopecia
  2. Increased risk of infection
  3. Paresthesias
  4. Skin reactions

(Rarely face edema, flushing, oral disorders, skin hemorrhage, and skin neoplasms)

23
Q

Is eflornithine safe to use in pregnancy and breastfeeding?

A

No, avoid

24
Q

Use of cyproterone acetate, including co-cyprindiol, for all indications is contra-indicated in those with _____________ or a history of ______________

A

meningioma

meningioma

25
Q

What are the contra-indications to using co-cyprindiol? (13)

A
  1. Acute porphyrias
  2. Current breast cancer
  3. Heart disease associated with pulmonary HTN and risk of embolus
  4. History of stroke or TIA
  5. IHD
  6. Known thrombogenic mutations
  7. Medical treatment of varicose veins
  8. Migraine with aura
  9. Positive antiphospholipid antibodies
  10. Presence or history of liver tumors
  11. Previous or current venous or arterial thrombosis
  12. Severe or multiple risk factors for arterial or venous thrombosis may
  13. SLE with antiphospholipid syndrome

(Same contraindications as for estrogen)

26
Q

There is an increased risk of ________________ in women taking co-cyprindiol, particularly during the first year of use.

A

venous thromboembolism

  • The incidence of venous thromboembolism is 1.5–2 times higher in women using co-cyprindiol than in women using combined oral contraceptives containing levonorgestrel, but the risk may be similar to that associated with use of combined oral contraceptives containing third generation progestogens (desogestrel and gestodene) or drospirenone. Women requiring co-cyprindiol may have an inherently increased risk of cardiovascular disease.
27
Q

What are the common side effects of co-cyprindiol? (7)

A
  1. Abdominal pain
  2. Breast abnormalities
  3. Depression
  4. Headache
  5. Mood altered
  6. Nausea
  7. Weight changes
28
Q

Is co-cyprindiol an effective contraceptive?

A

Yes; however it should not be used solely for contraception but reserved for women who require treatment for androgen-dependent skin conditions. Patients should not take other hormonal contraceptives while being treated with co-cyprindiol.

29
Q

Is co-cyprindiol safe to use during pregnancy and breastfeeding?

A

Avoid during pregnancy due to risk of feminization of male fetus with cyproterone (anti-androgen)

Avoid if breastfeeding due to anti-androgen effects

30
Q

Is co-cyprindiol safe to use in hepatic and/or renal impairment?

A

Caution in hepatic impairment; avoid in severe or active disease

31
Q

What is the mechanism of action of finasteride?

A

A specific inhibitor of the enzyme 5α-reductase, which metabolises testosterone into the more potent androgen, dihydrotestosterone

32
Q

What are the indications of finasteride? (2)

A
  1. BPH

2. Androgenetic alopecia in men

33
Q

The MHRA has received reports of _____________ and, in rare cases, _____________ in men taking finasteride (Propecia®) for male pattern hair loss; _____________ is also associated with Proscar® for benign prostatic hyperplasia.

A

depression

suicidal thoughts

depression

  • Patients should be advised to stop finasteride immediately and inform a healthcare professional if they develop depression
34
Q

Finasteride should be used with caution in which patients?

A

Those with obstructive uropathy

35
Q

What is the common side effect of finasteride?

A

Sexual dysfunction

Rarely breast abnormalities, depression, infertility, testicular pain, palpitations, and angioedema

36
Q

Finasteride is excreted in semen and use of a condom is recommended if sexual partner is _______________.

A

pregnant or likely to become pregnant

37
Q

How does finasteride effect laboratory tests?

A

Decreases serum concentration of prostate cancer markers such as prostate-specific antigen; reference values may need adjustment.

38
Q

what patient and carer information should be given regarding finasteride? (2)

A
  1. Women of childbearing potential should avoid handling crushed or broken tablets
  2. Cases of male breast cancer have been reported; promptly report any changes in breast tissue such as lumps, pain, or nipple discharge
39
Q

Finasteride _____ (is/is not) prescribable in NHS primary care for the treatment of androgenetic alopecia in men.

A

Is NOT (in primary care)